Acesis biomed team

EXECUTIVE TEAM

Karatzas

COSTAS N. KARATZAS, MSC, PHD

CEO, DIRECTOR & CO-FOUNDER
READ BIO + -
  • Dr. Karatzas has extensive experience of over 35 years in the life sciences sector as a senior executive with demonstrated successes in building multi- disciplinary business and technology teams, product development, commercialization strategies and fund raising in private, public and listed organizations
  • Dr. Karatzas has 50 peer reviewed publications and is the inventor of 18 patents. Dr. Karatzas attended McGill University where he earned his Ph.D., in Molecular Biology and has completed McGill University's executive Development mini-MBA course. He was the co-recipient of the Scientific America 50 Award in his Leadership role in the Chemicals & Materials category
  • From 2009 to April 2021 was the Director of Business Development and Contracts Office at the Research Institute of the McGill University Health Center, Montreal, Canada responsible for business development, key contract negotiations, technology transfer, commercialization, fund raising and spearheading major multimillion international alliances between academic and government organizations
  • Previous appointments with Pharming B.V., and member of the executive teams at AgroCultures Biotechnologies Inc., Nexia Biotech., (TSX) and PharmAthenelnc. (NYSE)
Karatzas

VASSILIOS PAPADOPOULOS, DPHARM, PHD

CHAIRMAN OF SAB, DIRECTOR & CO-FOUNDER
READ BIO + -
  • Dr. Papadopoulos is Dean of the University of Southern California Alfred Mann School of Pharmacy & Pharmaceutical Sciences. He holds the John Stauffer Decanal Chair in Pharmaceutical Sciences and is a professor of Pharmacology and Pharmaceutical Sciences and Medicine at USC. Before joining USC, Dr Papadopoulos served as Executive Director and Chief Scientific Officer of the Research Institute of McGill University Health Centre in Montreal
  • Dr. Papadopoulos has published more than 400 papers, holds numerous patents, serves on many national and international advisory committees and boards of biotechnology companies, and has been a consultantfor the pharmaceutical industry
  • He is an elected foreign member of the National Academies of Medicine and Pharmacy in France and a fellow of the American Association for the Advancement of Science, the American Association of Pharmaceutical Scientists, the Canadian Academy of Health Sciences, and the Royal Society of Canada
  • Dr. Papadopoulos is a leading authority in the field of steroid and neurosteroid biosynthesis. His research focuses on the pathophysiology and treatment of diseases related to altered steroid hormone synthesis.
Karatzas

THOMAS OLSON

COO
READ BIO + -
  • Mr. Olson is the owner, manager and sole member of Cresthill Associates, LLC, his privately held consulting firm offering comprehensive management and operations consulting solutions to companies since September 2008.
  • Mr. Olson has more than 35 years' experience working with public and private companies specializing in corporate operations and governance; with past experience in mergers and acquisitions and corporate finance. Mr. Olson has worked with a variety of public companies in various capacities, including as an executive officer or executive consultant, with listings ranging from US microcap markets through the NASDAQ stock market as well as the New York Stock Exchange

ADVISORS

Richard

JULIE POMEROY

Non-Executive Director Nominee
READ BIO + -
  • Ms. Pomeroy is an experienced finance director of public and private companies. Ms Pomeroy graduated with an honors degree in physics from Birmingham University and is a Chartered Accountant and Chartered Director. She also holds tax and treasury qualifications.
  • Ms Pomeroy is currently a non-executive Director of Dillistone Group Plc, an AIM quoted software business, and was finance director and company secretary. She is also non-executive chair of Oxford Cannabinoid Technologies Holdings Plc, which was admitted to the Official List (by way of a Standard Listing under Chapter 14 of the Listing Rules) and to trading on the London Stock Exchange's Main Market for listed securities in May 2021.
Richard

FREDERIC FASANO,DPharm. PhD

Non-Executive Director Nominee
READ BIO + -
  • Dr. Fasano is an experienced executive and director of several pharma, biotech, and medtech companies. He received his MBA from ESSEC Business School - France and his DPharm. PhD from Pharmacy School Paris XI-France.
  • Dr. Fasano was President, CEO, a board member, and an audit committee member at Valeo Pharma (TSX: VPH, OTCQB: VPHIF). In these roles, Dr. Fasano led the business operations, corporate strategy, and financial raises (including investor relationships, roadshows, and investor conferences). Dr. Fasano also served as CEO of Servier Canada Inc., a $350 million revenue company with 340 employees, and served as a board member of: ILKOS Therapeutics and Innovative Medicine Canada. In addition, he was CEO of IFB Stroder and Servier, Italy, pharmaceutical companies.
Richard

OSKAR SLINGERLAND

Non-Executive Director Nominee
READ BIO + -
  • Mr. Slingerland is an experienced entrepreneur and director of public and private companies. Mr. Slingerland was CEO of FRISOL Group (which later merged into NORTH SEA Group and, after that, ARGOS), a company with over 300 employees and a $10 billion turnover. This company was part of Petroplus International N.V., a Dutch public company listed on the Amsterdam Stock Exchange (AEX) until 2006, and now is part of VARO Energy.
  • Mr. Slingerland serves as a non-executive director of the oil trading company OES S.A.M. and has served as a director of several private and public companies during his career in the oil, retail, and energy sectors. Mr. Slingerland is also a movie producer and is the owner/director of Lockerbie Productions, Inc. and Lockerbie Film.

SCIENTIFIC ADVISORY BOARD

Dr Vassilios

VASSILIOS PAPADOPOULOS
DPHARM, PHD

READ BIO + -

Chairmanof SAB

Director & Co-founder of Acesis BioMed

Received the Distinguished Andrologist awards of the American Society of Andrology

Served as President of the American Society of Andrology

Dr Vassilios

LEWIS BLUMENTHAL
MD

READ BIO + -

Retired Chairman of the Obstetrics and Gynecology departments at MetroSouth Medical Center

Achieved Clinical Assistant Professor level at University of Illinois

Dr Vassilios

RAVI KACKER
MD

READ BIO + -

Served as an Instructor in Urology at Beth Israel Deaconess Medical Center

Founder of MetroWest Urologic Associates

Co-founder & CEO of MHB Labs

Dr Vassilios

BARRY R. ZIRKIN
PHD

READ BIO + -

Retired Professor at the Johns Hopkins Bloomberg School of Public Health

Received the Distinguished Service and Distinguished Andrologist awards of the American Society of Andrology

Served as President of the American Society of Andrology

Dr Vassilios

PETER LIU
MD PHD

READ BIO + -

Investigator at the Lundquist Institut

Professor of Medicine in Residence David Geffen School - UCLA

President International Society of Andrology